Logo image of DXYZ

DESTINY TECH100 INC (DXYZ) Stock Overview

USA - NYSE:DXYZ - US25063F1075

28.07 USD
+6.77 (+31.78%)
Last: 10/1/2025, 8:39:22 PM
27.8 USD
-0.27 (-0.96%)
After Hours: 10/1/2025, 8:39:22 PM
Fundamental Rating

2

Taking everything into account, DXYZ scores 2 out of 10 in our fundamental rating. DXYZ was compared to 0 industry peers in the Unkown industry. While DXYZ seems to be doing ok healthwise, there are quite some concerns on its profitability. DXYZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DXYZ had positive earnings in the past year.
In the past year DXYZ had a positive cash flow from operations.
DXYZ Yearly Net Income VS EBIT VS OCF VS FCFDXYZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA 24.87%
ROE 25.63%
ROIC N/A
ROA(3y)3.44%
ROA(5y)N/A
ROE(3y)3.36%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DXYZ Yearly ROA, ROE, ROICDXYZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 20

1.3 Margins

DXYZ does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) -11882.45%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DXYZ Yearly Profit, Operating, Gross MarginsDXYZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -50K -100K

More info and screens

5

2. Health

2.1 Basic Checks

DXYZ has about the same amout of shares outstanding than it did 1 year ago.
DXYZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DXYZ Yearly Shares OutstandingDXYZ Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M 10M
DXYZ Yearly Total Debt VS Total AssetsDXYZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

DXYZ has an Altman-Z score of 60.05. This indicates that DXYZ is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for DXYZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 60.05
ROIC/WACCN/A
WACCN/A
DXYZ Yearly LT Debt VS Equity VS FCFDXYZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

DXYZ has a Current Ratio of 0.05. This is a bad value and indicates that DXYZ is not financially healthy enough and could expect problems in meeting its short term obligations.
DXYZ has a Quick Ratio of 0.05. This is a bad value and indicates that DXYZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
DXYZ Yearly Current Assets VS Current LiabilitesDXYZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 914.70% over the past year.
The Revenue for DXYZ has decreased by -136.44% in the past year. This is quite bad
EPS 1Y (TTM)914.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.43%
Revenue 1Y (TTM)-136.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-89.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DXYZ Yearly Revenue VS EstimatesDXYZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 0 100K 200K 300K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.86, the valuation of DXYZ can be described as correct.
When comparing the Price/Earnings ratio of DXYZ to the average of the S&P500 Index (27.79), we can say DXYZ is valued slightly cheaper.
Industry RankSector Rank
PE 15.86
Fwd PE N/A
DXYZ Price Earnings VS Forward Price EarningsDXYZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 476.3
EV/EBITDA N/A
DXYZ Per share dataDXYZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DXYZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DESTINY TECH100 INC

NYSE:DXYZ (10/1/2025, 8:39:22 PM)

After market: 27.8 -0.27 (-0.96%)

28.07

+6.77 (+31.78%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)09-04 2025-09-04
Earnings (Next)03-23 2026-03-23
Inst Owners4.07%
Inst Owner Change-7.54%
Ins Owners0.07%
Ins Owner Change-368.75%
Market Cap305.40M
AnalystsN/A
Price TargetN/A
Short Float %17.37%
Short Ratio3.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.86
Fwd PE N/A
P/S N/A
P/FCF 476.3
P/OCF 476.3
P/B 4.06
P/tB 4.06
EV/EBITDA N/A
EPS(TTM)1.77
EY6.31%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY0.21%
OCF(TTM)0.06
OCFY0.21%
SpS-0.01
BVpS6.92
TBVpS6.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 24.87%
ROE 25.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) -11882.45%
GM N/A
FCFM -394.83%
ROA(3y)3.44%
ROA(5y)N/A
ROE(3y)3.36%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 3.32%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 60.05
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)914.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-136.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-89.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y102.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y102.96%
OCF growth 3YN/A
OCF growth 5YN/A